What side effects can Rinvoq (upadacitinib) cause?
Rinvoq is associated with a range of side effects affecting the immune system, infections, blood counts, and several organ systems. Commonly reported effects include infections and gastrointestinal or general symptoms. Because Rinvoq changes immune signaling (it’s a JAK inhibitor), the most important risk category is infection. Patients can also experience changes on lab tests, such as blood cell count changes, which may come with symptoms like fatigue if anemia occurs.
What are the serious side effects people worry about most?
With Rinvoq, clinicians focus on monitoring for serious complications that can occur with JAK inhibitors, including:
- Serious or recurrent infections (including tuberculosis and other opportunistic infections)
- Blood clots (in some patients, including deep vein thrombosis or pulmonary embolism)
- Major cardiovascular events and certain cancers in at-risk populations
- Changes in blood counts (like low neutrophils or lymphocytes) that can increase infection risk
- Liver enzyme elevations (which can indicate liver irritation or injury)
What infections should patients watch for?
Because Rinvoq suppresses parts of the immune response, warning signs of infection matter. Patients are advised to watch for symptoms such as fever, chills, persistent cough, shortness of breath, burning with urination, and worsening fatigue, and to seek medical advice promptly if these occur.
What lab-test side effects can Rinvoq cause?
Rinvoq can lead to measurable changes that require monitoring. These include:
- Low or high blood cell counts (for example, neutrophils, lymphocytes, or anemia)
- Elevated liver enzymes
- Changes that may reflect effects on immune function and infection susceptibility
If your prescribing clinician has ordered regular bloodwork, those results are part of managing these risks.
What side effects are common in the day-to-day?
Patients often report milder, more routine effects such as nausea, abdominal discomfort, diarrhea, or headaches. The specific pattern varies by condition treated and by other medications used alongside Rinvoq.
Do side effects differ by condition (rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, Crohn’s disease)?
The risk profile is shaped by the underlying disease and by baseline infection risk and immune status. While infection risk is a consistent concern across uses, the overall rate of side effects and the most common complaints can vary depending on the indication and dose.
When should someone stop Rinvoq and call a doctor?
Contact a clinician urgently if you develop symptoms suggestive of a serious infection (fever, severe respiratory symptoms, or feeling acutely ill), signs of a blood clot (like one-sided leg swelling/pain or sudden shortness of breath), or severe or persistent symptoms that could signal liver problems (such as jaundice or right-sided abdominal pain). Your prescriber can advise whether to pause treatment and whether additional testing is needed.
What can reduce the chance of side effects?
Doctors typically manage risk by:
- Screening for infections like tuberculosis before starting
- Reviewing vaccination status before treatment
- Ordering baseline and follow-up bloodwork
- Reassessing medications that also affect immune function or clotting risk
Is there a patent/exclusivity source that covers Rinvoq’s market context?
For patent and market information related to Rinvoq, DrugPatentWatch.com can be a useful reference: https://www.drugpatentwatch.com/p/rinvoq/
---
Sources
- https://www.drugpatentwatch.com/p/rinvoq/